VapeRisk is an independent product-review and harm-reduction publication. No affiliate commission. No manufacturer samples. No sponsored content.
Two units of every device, bought at retail under non-press accounts. We pay sticker price; receipts are kept for audit.
Multiple reviewers across use patterns. Battery cycles, coil rotations, leak tracking, day-to-day behavior — all logged.
Aerosol analysis at Eurofins (ISO 17025). Heavy metals, carbonyls, particle size, nicotine concentration vs. spec.
Build, flavor, battery, throat hit, value, lab safety. Weights are public; raw scores are linked from every review.
Sarah covers FDA regulation and tobacco-policy enforcement. Six years at Reuters' Washington bureau before VapeRisk; JD from Georgetown Law.
Aisha runs our lab program and harm-reduction research. PhD in Toxicology from Imperial College London. Previously at Cancer Research UK.
Devon leads the device-review team. Twelve years building and reviewing hardware before VapeRisk; specialist in coils, batteries, and DIY safety.
Marcus tracks the industry — earnings, M&A, market share. Former equity analyst at Morgan Stanley covering consumer staples.
Liam covers EU, UK, and APAC regulation from London. Eight years at the FT covering tobacco, nicotine, and consumer health.
Jordan founded VapeRisk in 2020 after a decade at Wirecutter. Sets editorial standards, oversees the methodology, owns disclosures.
Reader subscriptions: 64%. Licensing of lab data to research institutions: 22%. Non-affiliate advertising (display, RFP, no commission): 14%.
Manufacturer samples, affiliate commissions, sponsored reviews, embargoed press access. Anyone offering gets logged in our public record.
None. VapeRisk is privately held by its founder and three editorial staff. We've turned down two acquisition offers and one tobacco-aligned investor.
We read every message. Tips are confidential. We respond to corrections within 48 hours.